Is OCUP or RYLD a better dividend investment in 2026?

OCUP currently yields 170.94% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: OCUP offers higher current income.

What is the dividend yield difference between OCUP and RYLD?

OCUP has a forward dividend yield of 170.94% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 158.55 percentage points.

Home › Compare › OCUP vs RYLD

OCUP vs RYLD: Dividend Comparison 2026

OCUP yields 170.94% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 OCUP wins by $49.52M in total portfolio value

INVESTMENT

TIME HORIZON10 years

OCUP

● Live price

170.94%

Share price

$1.17

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.57M

Annual income

$23,046,519.63

Full OCUP calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — OCUP vs RYLD

📍 OCUP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	OCUP	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, OCUP + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

OCUP pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCUP

Annual income on $10K today (after 15% tax)

$14,529.91/yr

After 10yr DRIP, annual income (after tax)

$19,589,541.69/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, OCUP beats the other by $19,587,261.15/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCUP + RYLD for your $10,000?

OCUP: 50%RYLD: 50%

100% RYLD50/50100% OCUP

Portfolio after 10yr

$24.81M

Annual income

$11,524,601.30/yr

Blended yield

46.46%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on OCUP right now

OCUP

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-6.1

Piotroski

3/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCUP buys

RYLD buys

No recent congressional trades found for OCUP or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricOCUPRYLD

Forward yield	170.94% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$49.57M ✓	$45.3K
Annual income after 10y	$23,046,519.63 ✓	$2,682.98
Total dividends collected	$46.28M ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: OCUP vs RYLD ($10,000, DRIP)

Year	OCUP Portfolio	OCUP Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$27,794	$17,094.02	$11,939	$1,239.34	+$15.9K → OCUP
2	$74,143	$44,402.93	$14,158	$1,382.89	+$60.0K → OCUP
3	$190,032	$110,699.08	$16,682	$1,532.59	+$173.3K → OCUP
4	$468,500	$265,166.46	$19,537	$1,687.64	+$449.0K → OCUP
5	$1,112,264	$610,968.56	$22,752	$1,847.20	+$1.09M → OCUP
6	$2,545,727	$1,355,604.69	$26,355	$2,010.43	+$2.52M → OCUP
7	$5,623,629	$2,899,701.52	$30,376	$2,176.45	+$5.59M → OCUP
8	$12,003,803	$5,986,519.26	$34,847	$2,344.43	+$11.97M → OCUP
9	$24,786,500	$11,942,431.58	$39,800	$2,513.54	+$24.75M → OCUP
10	$49,568,075	$23,046,519.63	$45,269	$2,682.98	+$49.52M → OCUP

OCUP vs RYLD: Complete Analysis 2026

OCUP — Stock

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.

Full OCUP Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this OCUP vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCUP vs SCHD OCUP vs JEPI OCUP vs O OCUP vs KO OCUP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.